Low Testosterone Research Study

The purpose of this study is to compare the effects of treatment with Androxal 12.5mg, 25 mg, placebo caplets, AndroGel 1.62% or placebo gel on sperm concentration and testosterone in men with low testosterone and normal sperm concentration.

This study will last for approximately 20 weeks with a total of 10 office visits, one of which is a 24 hour overnight stay.

You will be compensated for each completed office visit.

You may qualify if the following apply to you:
  • Overweight (BMI 25 to 42 kg/m2 inclusive) males age 18 to 60 inclusive.
  • Previously or concurrently diagnosed as having secondary hypogonadism characterized as having at least 2 consecutive morning testosterone assessments < 300 ng/dL, one of which must be confirmed at Baseline.

Think you might qualify? Got questions about the study? Great! Fill out our Volunteer Interest Form or give us a call for more information on this research study.